TrademarkDir
ASCLEPIX
LIVE

Serial Number

88944669

Owner

AsclepiX Therapeutics, Inc.

Attorney

Rachelle A. Dubow

Filing Date

Jun 2, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ASCLEPIX Trademark

Serial Number: 88944669 • Registration: 7507885

ASCLEPIX is a trademark filed by AsclepiX Therapeutics, Inc. on June 2, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

AsclepiX Therapeutics, Inc. (5 trademarks)

185 Hudson Street, Suite 2500
Jersey City, NJ 07311

Entity Type: 03

Trademark Details

Filing Date

June 2, 2020

Registration Date

September 17, 2024

Published for Opposition

March 9, 2021

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 17, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 12, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 12, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 6, 2024 SUPC
USE AMENDMENT FILED
May 1, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
May 1, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 12, 2023 EXRA
SOU EXTENSION 5 GRANTED
Oct 11, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 11, 2023 AITU
SOU EXTENSION 5 FILED
Oct 2, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 2, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 29, 2023 EXRA
SOU EXTENSION 4 GRANTED
Apr 27, 2023 EX4G
SOU EXTENSION 4 FILED
Apr 27, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 27, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 27, 2022 EXRA
SOU EXTENSION 3 GRANTED
Oct 25, 2022 EX3G
SOU EXTENSION 3 FILED
Oct 25, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 25, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 6, 2022 EXRA
SOU EXTENSION 2 GRANTED
May 4, 2022 EX2G
SOU EXTENSION 2 FILED
May 4, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
May 4, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 5, 2021 EXRA
SOU EXTENSION 1 GRANTED
Nov 3, 2021 EX1G
SOU EXTENSION 1 FILED
Nov 3, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 3, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 4, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 17, 2021 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 4, 2021 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 4, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 22, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 22, 2021 CRFA
ASSIGNED TO LIE
Jan 20, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 7, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 3, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 3, 2020 GNRT
NON-FINAL ACTION WRITTEN
Sep 3, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 2, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2020 NWOS
NEW APPLICATION ENTERED
Jun 5, 2020 NWAP

Related Trademarks

More from this Owner

ASCLEPIX

ASCLEPIX

ASCLEPIX THERAPEUTICS

ASCLEPIX THERAPEUTICS

ASCLEPIX THERAPEUTICS

ASCLEPIX THERAPEUTICS

AESLEPIX

AESLEPIX

ASCLEPIX THERAPEUTICS

ASCLEPIX THERAPEUTICS

ASCLEPIX THERAPEUTICS

ASCLEPIX THERAPEUTICS